Dr. Masuko studies immuno-oncology at the process level: membrane transport and redox regulation that shape tumor growth, metastasis, and drug resistance. He develops monoclonal antibodies and targeted delivery approaches, and profiles membrane and glyco-signatures to enable biomarker-guided therapies.